These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 8567978)

  • 1. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
    J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric phospholamban overexpression in transgenic mouse hearts.
    Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
    Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
    Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
    J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
    Haghighi K; Schmidt AG; Hoit BD; Brittsan AG; Yatani A; Lester JW; Zhai J; Kimura Y; Dorn GW; MacLennan DH; Kranias EG
    J Biol Chem; 2001 Jun; 276(26):24145-52. PubMed ID: 11328820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
    Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
    Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport.
    Waggoner JR; Ginsburg KS; Mitton B; Haghighi K; Robbins J; Bers DM; Kranias EG
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H698-703. PubMed ID: 19112098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.
    Zvaritch E; Backx PH; Jirik F; Kimura Y; de Leon S; Schmidt AG; Hoit BD; Lester JW; Kranias EG; MacLennan DH
    J Biol Chem; 2000 May; 275(20):14985-91. PubMed ID: 10809743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation.
    He H; Giordano FJ; Hilal-Dandan R; Choi DJ; Rockman HA; McDonough PM; Bluhm WF; Meyer M; Sayen MR; Swanson E; Dillmann WH
    J Clin Invest; 1997 Jul; 100(2):380-9. PubMed ID: 9218515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
    Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
    Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
    Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase.
    Loukianov E; Ji Y; Grupp IL; Kirkpatrick DL; Baker DL; Loukianova T; Grupp G; Lytton J; Walsh RA; Periasamy M
    Circ Res; 1998 Nov; 83(9):889-97. PubMed ID: 9797337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
    Brittsan AG; Carr AN; Schmidt AG; Kranias EG
    J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.
    Chu G; Carr AN; Young KB; Lester JW; Yatani A; Sanbe A; Colbert MC; Schwartz SM; Frank KF; Lampe PD; Robbins J; Molkentin JD; Kranias EG
    Cardiovasc Res; 2002 Apr; 54(1):105-16. PubMed ID: 12062367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
    Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
    Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
    Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
    J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
    Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
    Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
    J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
    Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.